Wajapeyee N - Search Results

1

Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.

Bugide S, Janostiak R, Wajapeyee N. Bugide S, et al. Among authors: wajapeyee n. Trends Cancer. 2018 Aug;4(8):553-566. doi: 10.1016/j.trecan.2018.06.004. Epub 2018 Jul 3. Trends Cancer. 2018. PMID: 30064663 Free PMC article. Review.

2

Oncogene-directed alterations in cancer cell metabolism.

Nagarajan A, Malvi P, Wajapeyee N. Nagarajan A, et al. Among authors: wajapeyee n. Trends Cancer. 2016 Jul;2(7):365-377. doi: 10.1016/j.trecan.2016.06.002. Epub 2016 Jun 27. Trends Cancer. 2016. PMID: 27822561 Free PMC article. Review.

3

MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Janostiak R, Rauniyar N, Lam TT, Ou J, Zhu LJ, Green MR, Wajapeyee N. Janostiak R, et al. Among authors: wajapeyee n. Cell Rep. 2017 Dec 5;21(10):2829-2841. doi: 10.1016/j.celrep.2017.11.033. Cell Rep. 2017. PMID: 29212029 Free PMC article.

4

Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.

Bugide S, Green MR, Wajapeyee N. Bugide S, et al. Among authors: wajapeyee n. Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3509-E3518. doi: 10.1073/pnas.1802691115. Epub 2018 Mar 26. Proc Natl Acad Sci U S A. 2018. PMID: 29581297 Free PMC article.

5

Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation.

Janostiak R, Vyas M, Cicek AF, Wajapeyee N, Harigopal M. Janostiak R, et al. Among authors: wajapeyee n. Exp Mol Pathol. 2018 Aug;105(1):41-49. doi: 10.1016/j.yexmp.2018.05.011. Epub 2018 May 28. Exp Mol Pathol. 2018. PMID: 29852185

6

RNA Modification Regulatory Genes in DNA Damage.

Janostiak R, Wajapeyee N. Janostiak R, et al. Among authors: wajapeyee n. Methods Mol Biol. 2019;1870:249-262. doi: 10.1007/978-1-4939-8808-2_19. Methods Mol Biol. 2019. PMID: 30539561

7

Dot Blot Analysis for Measuring Global N⁶-Methyladenosine Modification of RNA.

Nagarajan A, Janostiak R, Wajapeyee N. Nagarajan A, et al. Among authors: wajapeyee n. Methods Mol Biol. 2019;1870:263-271. doi: 10.1007/978-1-4939-8808-2_20. Methods Mol Biol. 2019. PMID: 30539562

8

Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathway.

Gupta R, Bugide S, Wang B, Green MR, Johnson DB, Wajapeyee N. Gupta R, et al. Among authors: wajapeyee n. Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4583-4591. doi: 10.1073/pnas.1821889116. Epub 2019 Feb 19. Proc Natl Acad Sci U S A. 2019. PMID: 30782837 Free PMC article.

9

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma.

Janostiak R, Malvi P, Wajapeyee N. Janostiak R, et al. Among authors: wajapeyee n. iScience. 2019 Jun 28;16:453-467. doi: 10.1016/j.isci.2019.06.001. Epub 2019 Jun 8. iScience. 2019. PMID: 31229894 Free PMC article.

10

Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression.

Malvi P, Janostiak R, Nagarajan A, Cai G, Wajapeyee N. Malvi P, et al. Among authors: wajapeyee n. PLoS Genet. 2019 Oct 7;15(10):e1008439. doi: 10.1371/journal.pgen.1008439. eCollection 2019 Oct. PLoS Genet. 2019. PMID: 31589613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters